New eye surgery painkiller aims for faster recovery, fewer side effects
NCT ID NCT07269106
Summary
This study is testing if a new pain medication called Anrikefon works as well as a commonly used drug (nalbuphine) for managing pain after eye surgery. Researchers want to see if it provides similar pain relief but causes less drowsiness or dizziness, and if it helps patients recover and go home faster. About 204 adults having eye surgery will receive one of the two drugs during their procedure and be closely monitored afterwards.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eye & ENT Hospital of Fudan University
NOT_YET_RECRUITINGShanghai, 200031, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Affiliated Hospital of Yunnan University
NOT_YET_RECRUITINGKunming, Yunnan, 650000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhongshan Ophthalmic Center, Sun Yat-Sen University
RECRUITINGGuangzhou, Guangdong, 510060, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.